Sales suspension of 91 products not using Chinese ‘Valsartan’ cancelled
The sales suspension on the 91 antihypertensives that was confirmed not to use Chinese ‘Valsartan’ will be cancelled.
The Ministry of Food and Drug Safety(Minister Young-Jin Ryu) inspected 187 of 219 antihypertensives which have possibility to be used with ‘Valsartan,’ an active pharmaceutical i...
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.